Jones Trading Raises Relay Therapeutics Price Target to $31 From $20
Jones Trading raised its price target on Relay Therapeutics (RLAY) to $31 from $20, Dow Jones Newswires reported, citing Benzinga ratings data.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Jones Trading has raised its price target on Relay Therapeutics shares to $31 per share from $20, Dow Jones Newswires reported. The information comes from Benzinga's analyst ratings data.
why it matters
A price target is an analyst's estimate of where a stock could trade, not a forecast of actual price moves. Changes like this mainly matter to investors following Relay Therapeutics, with limited effect on the broader market.
tags
instruments
sources
- Relay Therapeutics Price Target Raised to $31.00/Share From $20.00 by Jones Trading — Dow Jones Newswires, 7 November 2026 at 00:57 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗